Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
DOD says it will act on biotechnology commission recommendations and explore mil‑spec guidance
Summary
Members pressed Defense Department witnesses to respond to recommendations from the National Security Commission on Emerging Biotechnology; officials said the department has an R&E principal director overseeing biotech investments and will review commission recommendations about mil‑spec guidance and contracting.
Defense Department witnesses told the House Armed Services Committee on Oct. 11 they are taking the National Security Commission on Emerging Biotechnology's recommendations seriously and will coordinate departmental efforts around biotechnology investments.
A committee member asked whether biotech would be part of the department's top technology priorities. A senior DOD witness said biotech is included among the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
